Coating processes – Medical or dental purpose product; parts; subcombinations;... – Implantable permanent prosthesis
Reexamination Certificate
2003-10-02
2009-12-01
Cameron, Erma (Department: 1792)
Coating processes
Medical or dental purpose product; parts; subcombinations;...
Implantable permanent prosthesis
C427S002250
Reexamination Certificate
active
07625593
ABSTRACT:
A method of manufacturing a drug-eluting coating for a stent is disclosed. A method for increasing blood flow to ischemic tissues by implanting the stent is also disclosed.
REFERENCES:
patent: 4990333 (1991-02-01), Lane et al.
patent: 5866113 (1999-02-01), Hendriks et al.
patent: 5897911 (1999-04-01), Loeffler
patent: 5957972 (1999-09-01), Williams et al.
patent: 6071305 (2000-06-01), Brown et al.
patent: 6206914 (2001-03-01), Soykan et al.
patent: 6299604 (2001-10-01), Ragheb et al.
patent: 6334872 (2002-01-01), Termin et al.
patent: 6379379 (2002-04-01), Wang
patent: 6391052 (2002-05-01), Buirge et al.
patent: 6395023 (2002-05-01), Summers
patent: 6436135 (2002-08-01), Goldfarb
patent: 6506437 (2003-01-01), Harish et al.
patent: 6517888 (2003-02-01), Weber
patent: 6610087 (2003-08-01), Zarbatany et al.
patent: 6663607 (2003-12-01), Slaikeu et al.
patent: 2002/0081732 (2002-06-01), Bowlin et al.
patent: 2003/0027751 (2003-02-01), Kovesdi et al.
Buschmann et al.,Arteriogenesis Versus Angiogenesis: Two Mechanisms of Vessel Growth, News Physiol: Sci., vol. 14, pp. 121-125 (Jun. 1999).
Heeschen et al.,Nicotine Stimulates Tumor Angiogenesis, Abstract, American College of Cardiology 50th Annual Scientific Session, Stanford, California, Mar. 18, 2001 (1 page).
Helisch et al.,Angiogenesis and arteriogenesis—not yet for prescription, Z Kardiol, 89, pp. 239-244 (2000).
Ito et al.,Monocyte Chemotactic Protein-1 Increases Collateral and Peripheral Conductance After Femoral Artery Occlusion, Circulation Research, vol. 80, No. 6, pp. 829-837 (Jun. 1997).
Kipshidze et al.,Therapeutic Angiogenesis for Critical Limb Ischemia to Limit or Avoid Amputation, The Journal of Invasive Cardiology, vol. 11, No. 1, pp. 25-28 (Jan. 1999).
Klugherz et al.,Gene delivery from a DNA controlled-release stent in porcine coronary arteries, Nature Biotechnology, vol. 18, pp. 1181-1184 (Nov. 2000).
Li et al.,PR39, a peptide regulator of angiogenesis, Nature Medicine, vol. 6, No. 1, pp. 49-55 (Jan. 2000).
Penta et al.,Del1 Induces lntegrin Signaling and Angiogenesis by Ligation of aVβ3, J. Biolog. Chem. 274(16):11101-11109 (Apr. 16, 1999).
Simons et al.,Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus. An Expert Panel Summary, Circulation, pp. 1-14, (Sep. 2000).
Zheng et al.,Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta, AJP—Heart and Circulatory Physiology, vol. 280, Issue 2, H909-H917 (Feb. 2001).
Consigny Paul
Hossainy Syed Faiyaz Ahmed
Mandrusov Evgenia
Mirzaee Dary
Advanced Cardiovascular Systems Inc.
Cameron Erma
Squire Sanders & Dempsey L.L.P.
LandOfFree
Method of manufacturing a stent coating and a method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of manufacturing a stent coating and a method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of manufacturing a stent coating and a method of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4070778